Houston Area Pediatric Specialists

Independent pediatric specialists aim to serve our community. We want to share news and analysis regarding our specialties and our practices.


Sunday, July 28, 2013

Evaluation & Treatment of Abnormal Facial Movements after Bells Palsy / Facial Nerve Palsy.



After Bell's Palsy  or Facial nerve palsy   Nerves can regrow into muscles that were not originally mapped  together.  Some people will have problems with activating individual muscles like they did before. 

I see patients who will wink and smile the same time or who will tear when they taste spicy food.

 Parents and physicians should note that this can be successfully treated. - JR


 2010;32(17):1414-8. doi: 10.3109/09638280903514697.

Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy.

Source

Department of Physical Medicine and Rehabilitation, University of Pavia, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy. elena.dallatoffola@unipv.it

Abstract

PURPOSE:

To assess the effect and efficacy of botulinum toxin type A (BTX-A) in reducing synkinesis in aberrant facial nerve regeneration (following facial paralysis).

METHOD:

A total of 55 sessions of BTX-A (Botox) infiltration were performed on 30 patients (23 female) with synkinesis after facial palsy. Each subject was injected with 2.5 units of BTX-A in each injection site (the sites were chosen on a case-by-case basis). The synkinetic muscles targeted include: orbicularis oculi, zygomaticus major, depressor labii inferioris, platysma, healthy frontalis and healthy corrugator supercilii. The patients were examined using the Sunnybrook Facial Grading System, both before the BTX-A treatment and after an average of 35 days.

RESULTS:

All 30 patients experienced improvement to the synkinesis after treatment. Total scores: median pre-BTX-A: 40; post 53 p = 0.004. Resting symmetry scores: mean pre-BTX-A -7.1; post: -3.5; median pre -5 [interquartile range (IQR) -10 to -5]; post: -5 (IQR -5 to 0); p = 0.0001. Symmetry of voluntary movement median pre-BTX-A: 56 post 60 p = 0.10. Synkinesis scores: median pre-BTX-A: -9 post -3 p < 0.0001. Mean duration of improvement was 4 months.

CONCLUSIONS:

BTX-A injection treatment was effective in reducing facial synkinesis, thus improving facial expression symmetry both at rest and in voluntary movements.

No comments:

Post a Comment